Trial intelligence / Profile preview

Danning Tablet for gallbladder polypoid lesions

ChiCTR2200067204Phase 4Not yet recruiting

Sponsor
Third Affiliated Hospital of Naval Medical University
Start
Dec 2022
Countries
1
01

Overview

Phase 4, open-label trial of Danning Tablet in gallbladder polyp (2 arms), sponsored by Third Affiliated Hospital of Naval Medical University. Primary endpoint: Change in maximum diameter of gallbladder polyps. Planned start Dec 2022; status: not yet recruiting.

02

Drugs

Danning Tablet
03

Conditions

gallbladder polyp

Beyond the preview

Go deeper on ChiCTR2200067204.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200067204.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call